ARTICLE | Clinical News
Cytochroma reports data for vitamin D insufficiency
May 12, 2012 12:34 AM UTC
Cytochroma Inc. (Markham, Ontario) said CTAP101 significantly reduced mean intact parathyroid hormone (PTH) levels from baseline to week six vs. placebo in a Phase IIb trial to treat vitamin D insuffi...